Skip to main content
. 2018 May 12;68(1):22–28. doi: 10.1093/cid/ciy399

Figure 1.

Figure 1.

Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. aureus (MSSA) hospitalizations, 2010–2014. The excess cost of MRSA-related hospitalizations compared wth MSSA-related hospitalizations was measured as the mean cost of MRSA-related hospitalizations minus the mean cost of MSSA-related hospitalizations. The arrows indicate the 95% confidence interval of the difference in the means. The negative values indicate that MRSA-related hospitalizations were, on average, less costly than similar MSSA-related hospitalizations. The stars indicate the P-value of whether the mean was significantly different from 0 at P < .05 (*) or P < .01 (**).